June 2020 Newsletter


D’Aquila Named Director of NUCATS Institute

Richard D’Aquila, MD  has been selected to lead the Northwestern University Clinical and Translational Sciences (NUCATS) Institute, effective June 1. Dr. D’Aquila will continue to direct the Third Coast CFAR and looks forward to promoting new opportunities for collaborative research. 

Read more>>

Call for Abstracts & Early Registration: Midwest LGBTQ Health Symposium

Join Howard Brown’s Center for Education, Research and Advocacy for the sixth Midwest LGBTQ Health Symposium (MLHS) on September 16-17, 2020 at Malcolm X College in Chicago, IL. The Midwest LGBTQ Health Symposium brings together over 500 healthcare professionals, social service providers, advocates and researchers to highlight innovative practices in LGBTQ patient-centered clinical care as well as community-driven approaches to addressing health disparities. This year, the Planning Committee is excited to gather passionate healthcare professionals to join in sharing advances in LGBTQ Health and Wellness for this year’s theme, “Being Healthy is a Radical Act.”  The MLHS 2020 keynote speakers are Imani Rupert-Gordon, Executive Director of National Center for Lesbian Rights and Shannon Weber, MSW Founder and Director of PleasePrEPMe.


Birkett Awarded R01 to Use Simulation Modeling to Understand HIV Health Disparities Among Racial and Sexual Minorites in Chicago

The Third Coast CFAR would like to congratulate Michelle Birkett, PhD, on her new R01, which will use simulation modeling to understand HIV disparities among racial and sexual minorities in Chicago. The project joins experts in HIV epidemiology, network science, computational modeling, and health disparities research from both Northwestern and the University of Chicago/Argonne National Laboratory. A core subsidy award from the CFAR aided Dr. Birkett and her team during the proposal development phase of the project.
Read more>>

RADAR Study renewed with 13.7 Million Dollar Grant


The RADAR study at Northwestern’s Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH) was recently awarded a $13.7 million, five-year grant from the National Institute on Drug Abuse of the NIH. The award will allow RADAR to advance and expand its innovative research on HIV, relationships, and substance use among young men who have sex with men (MSM), transgender women, and nonbinary individuals assigned male at birth in Chicago. CFAR co-director Brian Mustanski, PhD, is the project’s principal investigator (PI).


Moskowitz Presents Webinar on Positive Emotion Interventions During COVID-19 

On May 21, 2020, Judith Moskowitz, PhD, MPH, presented “Can Positive Emotion Interventions Help for Coping with the Stress of a Global Pandemic?” in the Institute for Public Health and Medicine (IPHAM) webinar series. Moskowitz’s research examines the unique adaptive role of positive emotion in the process of coping with various types of health-related and other life stress. Through randomized trials, her team determines whether a positive emotion regulation intervention can increase positive affect, reduce stress and depression, and improve health behaviors. Dr. Moskowitz directs the CFAR’s Behavioral, Social, and Implementation Sciences (BSIS) Core and is a professor of Medical Social Sciences at Northwestern University.
View the webinar here>>

July 3 Abstract Deadline for HIV and Aging Workshop

The 11th edition of the International Workshop on HIV & Aging will be held on October 1-2, 2020 in New York City, New York. The 2020 meeting will gather a cross-disciplinary team of experts, trainees, and community members who are involved in HIV and aging research and the provision of care to older persons living with HIV.  The ultimate goals of this conference are to stimulate and guide research that will enable better treatment methods and strategies for older adults with HIV, to encourage young investigators, and to stimulate new partnerships between investigators in HIV and aging. 

Read more>>  



Third Coast CFAR Event

Ravi Jhaveri, MD
Associate Division Head Pediatric Infectious Diseases
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine

Universal Screening for Hepatitis C virus: How we got here and the road ahead
Monday, June 8, 2020
12–1 p.m. CT
RSVP Required 

Dr. Jhaveri joined the faculty at Lurie/FSM in October 2018 after having served on the faculty at both Duke and UNC. He currently serves as Associate Division Head for Pediatric Infectious Diseases. Dr. Jhaveri is active in leadership of several infectious diseases society at the national level. He currently serves as a member of the Pediatric Infectious Diseases Society Board of Directors. He is the Vice-Chair of the Infectious Diseases Society of America Leadership Institute working group and is the PIDS liaison to the IDSA Standards, Practice and Guidelines Committee. He is a member of the AASLD-IDSA HCV Guidelines committee where he serves as one of the subgroup chairs on HCV in Children and Pregnant Women.
Dr. Jhaveri has focused on all aspects of Hepatitis C virus infection. In the past, he ran a laboratory dedicated to study the effect of HCV on lipid metabolism in liver cells and viral and host determinants of HCV vertical transmission. He has been very active in studies of HCV in infants and children: epidemiology, natural history and treatment, testing and advocacy. Dr. Jhaveri’s other interests include outcomes studies in pediatric infectious diseases, influenza and the live-attenuated influenza vaccine, prevention, treatment and vertical transmission of Hepatitis B, management of febrile infants and physician decision-making.

RSVP on Zoom

New Funding Opportunities

NIH Notices pertaining to HIV/AIDS
Notice of Special Interest (NOSI): HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in HRSA Primary Health Care Settings (Admin Supp)
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions
Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience
HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative
Supplements to Support Strategies to Reduce Stigma in Pain Management and Opioid Use Disorder (OUD) and Treatment

Funding Opportunities Pertaining to HIV/AIDS
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion:  CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
Application Receipt Date(s): July 20, 2020
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed)
Application Receipt Date(s): September 7, 2020
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)
Application Receipt Date(s): July 28, 2020; July 28, 2021; July 28, 2022

Copyright © 2020 Third Coast Center for AIDS Research, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp